Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

iBio Inc

IBIO
6,33
0,00 (0,00%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 01:00:00
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/3/202522:05EDGAR2Form 25 - Notification of the removal from listing and..
03/3/202516:25EDGAR2Form CERT - Certification by an exchange approving..
03/3/202512:30EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
24/2/202512:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202512:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202512:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202522:25EDGAR2Form 8-K - Current report
19/2/202522:05GLOBEiBio to Begin Trading on the Nasdaq Stock Exchange
11/2/202522:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/2/202522:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/2/202522:06EDGAR2Form 8-K - Current report
10/2/202522:05GLOBEiBio Reports Fiscal Second Quarter 2025 Financial Results
31/1/202523:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
31/1/202523:11EDGAR2Form S-3 - Registration statement under Securities Act of..
13/1/202522:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202522:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202522:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202513:55EDGAR2Form 8-K - Current report
13/1/202513:00GLOBEiBio Announces New Investments from Board Members and..
10/1/202513:47EDGAR2Form 8-K - Current report
07/1/202513:00GLOBEiBio Discovers Novel Antibody Targeting Activin E in..
02/1/202513:36EDGAR2Form 8-K - Current report
02/1/202513:00GLOBEiBio Expands Cardiometabolic and Obesity Program with..
09/12/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202423:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/11/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202414:30EDGAR2Form 8-K - Current report
25/11/202414:00GLOBEiBio Strengthens Board with Appointment of Two New..
15/11/202402:47EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
14/11/202422:48EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:06EDGAR2Form 8-K - Current report
12/11/202422:05GLOBEiBio Reports Fiscal First Quarter 2025 Financial Results
23/10/202415:12EDGAR2Form 8-K - Current report
10/10/202422:10EDGAR2Form DEF 14A - Other definitive proxy statements
10/10/202414:00GLOBEiBio and AstralBio Provide Update on Myostatin Program for..
24/9/202422:11EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
20/9/202422:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/9/202422:07EDGAR2Form 8-K - Current report
20/9/202422:05GLOBEiBio Reports Fiscal Year 2024 Financial Results and Provides..
03/9/202413:00GLOBEiBio to Participate in Upcoming Investor Conferences
12/8/202422:30GLOBEiBio Expands Executive Leadership Team with Appointment of..
06/8/202423:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/7/202415:03EDGAR2Form 8-K - Current report
25/7/202423:05EDGAR2Form S-3/A - Registration statement under Securities Act of..
09/7/202422:02EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 6,33

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network